NasdaqGM - Delayed Quote USD
Oculis Holding AG (OCS)
17.32
+0.04
+(0.23%)
As of May 14 at 4:00:00 PM EDT. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-52,742
-47,499
-53,845
-25,074
-13,825
Investing Cash Flow
-67,550
-17,557
-54,211
-3,548
-28
Financing Cash Flow
157,690
54,030
129,672
1,714
55,194
End Cash Position
61,759
27,708
38,327
19,786
46,277
Capital Expenditure
-2,052
-230
-48
-3,548
-28
Issuance of Capital Stock
143,768
53,541
135,615
2,030
56,096
Repayment of Debt
-317
-274
-158
-159
-98
Free Cash Flow
-54,072
-47,729
-53,893
-28,622
-13,853
12/31/2021 - 5/18/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
AVBP ArriVent BioPharma, Inc.
18.78
+0.16%
207940.KS Samsung Biologics Co.,Ltd.
998,000.00
-0.70%
OPT Opthea Limited
3.4100
+1.49%
IVA Inventiva S.A.
3.4969
-0.09%
BNTC Benitec Biopharma Inc.
12.67
-6.70%
CAMX.ST Camurus AB (publ)
544.00
-12.47%
XBRANE.ST Xbrane Biopharma AB (publ)
0.2478
-0.88%
MBX MBX Biosciences, Inc.
9.99
-1.82%
LENZ LENZ Therapeutics, Inc.
27.85
+0.78%
9EN.F Pharvaris N.V.
14.00
0.00%